Initiating treatment for patients with cancer associated thrombosis is now easier than ever before.  Our pharmacists will:

• review labwork and reconcile meds

• weigh the patient

• initiate therapy with low weight molecular heparin x 14 days *physician to renew rx within 14 days*

• administer the first dose and train the patient on self-administration using a bruiseless subcutaneous injection technique

• follow up by phone the next day

• order a lab requisition to monitor platelets for heparin-induced thrombocytopenia

• Communicate a summary to the patient's family physician and their oncologist.

​

The pharmacist will contact the referring oncologist before proceeding if:

• labwork is over 14 days old, and no new labwork was completed with results pending

• platelet count is below 50 000

• clotting or bleeding disorder that was not identified on the form completed by the oncologist

• patient is taking warfarin and INR is over 3, or no labwork in the past 14 days

​

​

Our pharmacists have received specialized training to initiate therapy for thromboprophylaxis in pregnancy.  On referral, the pharmacist will:

• review labwork and reconcile meds, order baseline labwork if needed

• weigh the patient

• initiate therapy with low weight molecular heparin x 10 weeks

• administer the first dose and train the patient on self-administration using a bruiseless subcutaneous injection technique

• follow up by phone the next day

• order a lab requisition to monitor platelets for heparin-induced thrombocytopenia

• communicate a summary to the patient's family physician

​

​

​